Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: CUBRC, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-08-16 to 2026-02-28
Current total value of award: $1014000
Description: DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY